Laiyemo Adeyinka O, Pinsky Paul F, Marcus Pamela M, Lanza Elaine, Cross Amanda J, Schatzkin Arthur, Schoen Robert E
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA.
Clin Gastroenterol Hepatol. 2009 May;7(5):562-7; quiz 497. doi: 10.1016/j.cgh.2008.12.009. Epub 2008 Dec 13.
Prospective information on the use and yield of surveillance colonoscopy is limited. We examined the use and yield of surveillance colonoscopy among participants in the Polyp Prevention Trial (PPT) after the 4-year dietary intervention trial ended.
We followed a cohort of 1297 participants. We calculated the cumulative probability of posttrial colonoscopy and investigated the yield and predictive factors for adenoma and advanced adenoma recurrence over a mean time of 5.9 years.
Seven-hundred seventy-four subjects (59.7%) had a repeat colonoscopy. Among 431 subjects with low-risk adenomas (1-2 nonadvanced adenomas) at baseline and no adenoma recurrence at the end of the PPT (lowest-risk category), 30.3% underwent a repeat colonoscopy within 4 years. Among 55 subjects who had high-risk adenomas (advanced adenoma and/or > or =3 nonadvanced adenomas) at baseline and again at the final PPT colonoscopy (highest-risk category), 41.3% had a colonoscopy within 3 years and 63.5% had an examination within 5 years. The cumulative yield of advanced adenoma through 6 years was 3.6% for the lowest-risk category, 38.9% for the highest-risk category, and ranged from 6.6% to 13.8% for intermediate-risk categories. An advanced adenoma at the final PPT colonoscopy was associated significantly with an advanced adenoma recurrence during surveillance (hazard ratio, 6.2; 95% confidence interval, 2.5-15.4).
Surveillance colonoscopy was overused for low-risk subjects and underused for high-risk subjects. Advanced adenoma yield corresponded with the adenoma risk category. Resource consumption can be better managed by aligning use with the risk of adenoma recurrence.
关于监测性结肠镜检查的使用情况及检出率的前瞻性信息有限。我们在为期4年的饮食干预试验结束后,对息肉预防试验(PPT)参与者中监测性结肠镜检查的使用情况及检出率进行了研究。
我们对1297名参与者组成的队列进行了随访。我们计算了试验后结肠镜检查的累积概率,并调查了在平均5.9年的时间里腺瘤和高级别腺瘤复发的检出率及预测因素。
774名受试者(59.7%)接受了重复结肠镜检查。在基线时患有低风险腺瘤(1 - 2个非高级别腺瘤)且在PPT结束时无腺瘤复发的431名受试者(最低风险类别)中,30.3%在4年内接受了重复结肠镜检查。在基线时患有高风险腺瘤(高级别腺瘤和/或≥3个非高级别腺瘤)且在PPT最后一次结肠镜检查时仍为高风险腺瘤的55名受试者(最高风险类别)中,41.3%在3年内接受了结肠镜检查,63.5%在5年内接受了检查。低风险类别在6年内高级别腺瘤的累积检出率为3.6%,高风险类别为38.9%,中风险类别为6.6%至13.8%。PPT最后一次结肠镜检查时的高级别腺瘤与监测期间高级别腺瘤复发显著相关(风险比,6.2;95%置信区间,2.5 - 15.4)。
监测性结肠镜检查在低风险受试者中使用过度,而在高风险受试者中使用不足。高级别腺瘤的检出率与腺瘤风险类别相符。通过使检查的使用与腺瘤复发风险相匹配,可以更好地管理资源消耗。